41.21
Sionna Therapeutics Inc Aktie (SION) Neueste Nachrichten
Sionna Therapeutics chief legal officer sells $415,330 in stock By Investing.com - Investing.com India
Sionna Therapeutics chief legal officer sells $415,330 in stock - Investing.com
Sionna Therapeutics Insider Sold Shares Worth $415,330, According to a Recent SEC Filing - marketscreener.com
Bosun Asset Management LLC Invests $295,000 in Sionna Therapeutics, Inc. $SION - Defense World
Officer Fitzpatrick Files To Sell 10,250 Of Sionna Therapeutics Inc [SION] - TradingView
Sionna Therapeutics, Inc. $SION Shares Acquired by Prudential Financial Inc. - MarketBeat
Sionna Therapeutics (NASDAQ:SION) Shares Up 11.4%What's Next? - MarketBeat
Sionna Therapeutics Valuation Topping $2 Billion Is 'Too Optimistic', RBC Says - marketscreener.com
Transcript : Sionna Therapeutics, Inc. Presents at Citi Annual Global Healthcare Conference 2025, Dec-04-2025 09 - marketscreener.com
Why Sionna Therapeutics Inc. stock remains resilient2025 Short Interest & Long-Term Growth Portfolio Plans - Newser
Will Sionna Therapeutics Inc. stock gain from government policies - Newser
Sionna Therapeutics, Inc. $SION Shares Purchased by JPMorgan Chase & Co. - MarketBeat
Sionna Therapeutics (NASDAQ:SION) Shares Gap DownHere's What Happened - MarketBeat
Views of Wall Street’s Leading Experts on Sionna Therapeutics Inc - Setenews
Royal Bank Of Canada Reiterates "Underperform" Rating for Sionna Therapeutics (NASDAQ:SION) - MarketBeat
Is Sionna Therapeutics Inc. stock affected by interest rate hikesGold Moves & Precise Entry and Exit Recommendations - Newser
Sionna Therapeutics Shares Lower After RBC Downgrade - marketscreener.com
Sionna Therapeutics stock tumbles after RBC downgrade By Investing.com - Investing.com Canada
SION Downgraded by RBC Capital: Today's Analyst Rating | SION St - GuruFocus
RBC Capital downgrades Sionna Therapeutics stock on valuation concerns By Investing.com - Investing.com Canada
RBC Downgrades Sionna Therapeutics to Underperform From Sector Perform, Keeps $24 Price Target, Speculative Risk - marketscreener.com
Sionna Therapeutics (NASDAQ:SION) Stock Price Down 3.9%Should You Sell? - MarketBeat
What drives Sionna Therapeutics Inc stock priceEarnings Forecast Updates & Rapid Capital Trading - earlytimes.in
Sionna Therapeutics (SION): Examining Valuation Following Recent Share Price Surge - Sahm
Sionna Therapeutics Insider Sold Shares Worth $4,814,205, According to a Recent SEC Filing - marketscreener.com
OrbiMed Advisors sells Sionna Therapeutics (SION) stock worth $4.8m By Investing.com - Investing.com Nigeria
Sionna Therapeutics (NASDAQ:SION) Director Sells $71,184.00 in Stock - MarketBeat
OrbiMed Advisors sells Sionna Therapeutics (SION) stock worth $4.8m - Investing.com India
Shareholder OrbiMed Advisors LLC Sells 108,073 ($4.8M) Of Sionna Therapeutics Inc [SION] - TradingView
Sionna Therapeutics(SION.US) Director Sells US$4.81 Million in Common Stock - 富途牛牛
Insider Selling: Sionna Therapeutics (NASDAQ:SION) Director Sells 25,183 Shares of Stock - MarketBeat
Major Stock Sale Alert: Sionna Therapeutics Shares on the Move! - TipRanks
Shareholder Orbimed Private Investments Viii Lp Files To Sell 1,047,770 Of Sionna Therapeutics Inc [SION] - TradingView
Owner RA Capital Management LP Sells 30,316 ($1.2M) Of Sionna Therapeutics Inc [SION] - TradingView
RA Capital funds report SION insider stock sales in Form 4 filing - Stock Titan
SION Crosses Above Average Analyst Target - Nasdaq
Sionna Therapeutics to Participate in Upcoming December Investor Conferences - The Manila Times
Sionna Therapeutics (NASDAQ:SION) Hits New 1-Year HighHere's What Happened - MarketBeat
Owner Blackwell Partners LLC-Series A Files To Sell 7,609 Of Sionna Therapeutics Inc [SION] - TradingView
Is Sionna Therapeutics Inc. stock a smart buy before Fed meetingGap Down & High Yield Equity Trading Tips - newser.com
Will Sionna Therapeutics Inc. stock reach Wall Street targetsMarket Risk Report & Reliable Intraday Trade Alerts - newser.com
Sionna Therapeutics (NASDAQ:SION) Upgraded at BTIG Research - Defense World
Ra Capital sold Sionna Therapeutics (SION) shares worth $5.5m By Investing.com - Investing.com UK
Ra Capital sold Sionna Therapeutics (SION) shares worth $5.5m - Investing.com
[Form 4] Sionna Therapeutics, Inc. Insider Trading Activity - Stock Titan
Owner RA Capital Management LP Sells 136,351 ($5.5M) Of Sionna Therapeutics Inc [SION] - TradingView
Sionna Therapeutics(SION.US) 10% Shareholder Sells US$5.5 Million in Common Stock - 富途牛牛
Is Sionna Therapeutics Inc. stock a safe buy before earningsTrade Risk Report & Risk Controlled Daily Plans - newser.com
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):